Novo Nordisk CEO Exit After Massive Sell-Off Hits Shares

Nauman khan

Fri, May 16, 2025, 2:05 PM 1 min read

May 16 - Novo Nordisk (NYSE:NVO) said CEO Lars Fruergaard Jrgensen will measurement down aft 8 years astatine the helm, pursuing a crisp diminution successful its stock terms implicit the past year.

Shares of the Denmark-based drugmaker person dropped implicit 50% implicit the past 12 months amid increasing marketplace pressures. The banal fell a further 4% connected Friday trading pursuing the enactment update.

• Warning! GuruFocus has detected 1 Warning Sign with NVO.

Jrgensen volition stay successful his relation temporarily portion the committee searches for a successor to guarantee a creaseless transition. Novo Nordisk said the alteration was driven by caller marketplace challenges, the stock terms decline, and the privation from the Novo Nordisk Foundation.

In a related move, the institution said Lars Rebien Srensen, existent Chairman of the Novo Nordisk Foundation and erstwhile CEO of Novo Nordisk, volition articulation the committee arsenic an observer. He is expected to beryllium nominated arsenic a afloat committee subordinate astatine the company's 2026 yearly meeting.

Srensen led the institution from 2000 to 2016, earlier handing implicit the reins to Jrgensen.

The enactment reshuffle marks a pivotal infinitesimal for Novo Nordisk arsenic it navigates marketplace headwinds and prepares for a strategical modulation astatine the top.

This nonfiction archetypal appeared connected GuruFocus.